Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-22

Clinical Trial Update: Lendormin D® Tablet (Drug Use Result Survey)

View source ↗

Summary

The clinical trial update indicates the study of Lendormin D Tablet for sleep initiation and maintenance disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lendormin D Tablet

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Sleep Initiation and Maintenance Disorders | Status: COMPLETED